Works matching AU Sugiyama, Eiji

Results: 85
    1
    2
    3
    4

    A report of three cases with lupus myelitis.

    Published in:
    European Journal of Rheumatology, 2017, v. 4, n. 2, p. 148, doi. 10.5152/eurjrheum.2017.160099
    By:
    • Hiroshi Oiwa;
    • Toru Yamabe;
    • Masanori Kawashima;
    • Yuta Maetani;
    • Dai Agari;
    • Takemori Yamawaki;
    • Eiji Sugiyama
    Publication type:
    Article
    5
    6
    7

    Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084
    By:
    • Tanaka, Yoshiya;
    • Matsubara, Tsukasa;
    • Atsumi, Tatsuya;
    • Amano, Koichi;
    • Ishiguro, Naoki;
    • Sugiyama, Eiji;
    • Yamaoka, Kunihiro;
    • Combe, Bernard G.;
    • Kivitz, Alan J.;
    • Sang-Cheol Bae;
    • Keystone, Edward C.;
    • Nash, Peter;
    • Genovese, Mark;
    • Matzkies, Franziska;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Akira Kondo;
    • Lei Ye;
    • Qi Gong;
    • Tasset, Chantal
    Publication type:
    Article
    8

    Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 4, p. 657, doi. 10.1093/mr/roac083
    By:
    • Atsumi, Tatsuya;
    • Tanaka, Yoshiya;
    • Matsubara, Tsukasa;
    • Amano, Koichi;
    • Ishiguro, Naoki;
    • Sugiyama, Eiji;
    • Yamaoka, Kunihiro;
    • Westhovens, René;
    • Ching, Daniel W. T.;
    • Messina, Osvaldo Daniel;
    • Burmester, Gerd R.;
    • Genovese, Mark;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Kondo, Akira;
    • Zhaoyu Yin;
    • Qi Gong;
    • Chantal Tasset;
    • Takeuchi, Tsutomu
    Publication type:
    Article
    9

    Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 1, p. 64, doi. 10.1093/mr/roac020
    By:
    • Naoki Ishiguro;
    • Yoshiya Tanak;
    • Tsukasa Matsubara;
    • Tatsuya Atsumi;
    • Koichi Amano;
    • Eiji Sugiyama;
    • Kunihiro Yamaoka;
    • Winthrop, Kevin;
    • Kivitz, Alan;
    • Burmester, Gerd R.;
    • Gottenberg, Jacques-Eric;
    • Genovese, Mark C.;
    • Matzkies, Franziska;
    • Ying Guo;
    • Deyuan Jiang;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Akira Kondo;
    • Besuyen, Robin;
    • Tsutomu Takeuchi
    Publication type:
    Article
    10

    Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study).

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 5, p. 846, doi. 10.1093/mr/roab090
    By:
    • Naoto Tamura;
    • Takanori Azuma;
    • Kenta Misaki;
    • Rei YamaguchiDivision of Rheumatology, Department of Internal Medicine,Tokyo Women's Medical University School of Medicine, Tokyo, Japan;
    • Fuminori Hirano;
    • Eiji Sugiyama;
    • Daisuke Kanai;
    • Yohko Murakawa;
    • Motohiro Oribe;
    • Takahito Kimata;
    • Kazutoshi Aoki;
    • Tomoko Sugiura;
    • Koji Takasugi;
    • Yuya Takakubo;
    • Yasuyuki Tomita;
    • Takeo Isozaki;
    • Toshihiro Nanki;
    • Naooki Katsuyama;
    • Takanori Kuroiwa;
    • Hideto Oshikawa
    Publication type:
    Article
    11

    Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030
    By:
    • Yoshiya Tanaka;
    • Tsukasa Matsubara;
    • Tatsuya Atsumi;
    • Koichi Amano;
    • Naoki Ishiguro;
    • Eiji Sugiyama;
    • Kunihiro Yamaoka…AUS-Department of Rheumatology and Infectious Diseases,Kitasato University School of Medicine, Kanagawa, Japan;
    • Combe, Bernard G.;
    • Kivitz, Alan J.;
    • Sang-Cheol Bae;
    • Keystone, Edward C.;
    • Nash, Peter;
    • Matzkies, Franziska;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Akira Kondo;
    • Lei Ye;
    • Ying Guo;
    • Tasset, Chantal;
    • Sundy, John S.
    Publication type:
    Article
    12

    Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 2, p. 273, doi. 10.1093/mr/roab021
    By:
    • Tatsuya Atsumi;
    • Yoshiya Tanaka;
    • Tsukasa Matsubara;
    • Koichi Amano;
    • Naoki Ishiguro;
    • Eiji Sugiyama;
    • Kunihiro Yamaoka;
    • Rene;
    • Westhovens;
    • Ching, Daniel W.T.;
    • Messina, Osvaldo Daniel;
    • Burmester, Gerd R.;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Akira Kondo;
    • Zhaoyu Yin;
    • Ying Guo;
    • Tasset, Chantal;
    • Sundy, John S.;
    • Tsutomu Takeuchi
    Publication type:
    Article
    13

    C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 1, p. 141, doi. 10.1080/14397595.2021.1907014
    By:
    • Yusuke Yoshida;
    • Tomohiro Sugimoto;
    • Yohei Hosokawa;
    • Harumichi Suma;
    • Hiroki Kobayashi;
    • Michinori Ishitoku;
    • Hiroki Kohno;
    • Tadahiro Tokunaga;
    • Hirofumi Watanabe;
    • Sho Mokuda;
    • Takaki Nojima;
    • Shintaro Hirata;
    • Eiji Sugiyama
    Publication type:
    Article
    14

    Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 1, p. 59, doi. 10.1080/14397595.2020.1859675
    By:
    • Tsutomu Takeuchi;
    • Tsukasa Matsubara;
    • Tatsuya Atsumi;
    • Koichi Amano;
    • Naoki Ishiguro;
    • Eiji Sugiyama;
    • Kunihiro Yamaoka;
    • Genovese, Mark C.;
    • Kalunian, Kenneth;
    • Walker, David;
    • Gottenberg, Jacques-Eric;
    • de Vlam, Kurt;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Kondo, Akira;
    • Gao, Jie;
    • Ying Guo;
    • Tasset, Chantal;
    • Sundy, John S.;
    • Yoshiya Tanakao
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    Glycosphingolipid metabolic reprogramming drives neural differentiation.

    Published in:
    EMBO Journal, 2018, v. 37, n. 7, p. 1, doi. 10.15252/embj.201797674
    By:
    • Russo, Domenico;
    • Della Ragione, Floriana;
    • Rizzo, Riccardo;
    • Sugiyama, Eiji;
    • Scalabrì, Francesco;
    • Hori, Kei;
    • Capasso, Serena;
    • Sticco, Lucia;
    • Fioriniello, Salvatore;
    • De Gregorio, Roberto;
    • Granata, Ilaria;
    • Guarracino, Mario R.;
    • Maglione, Vittorio;
    • Johannes, Ludger;
    • Bellenchi, Gian Carlo;
    • Hoshino, Mikio;
    • Setou, Mitsutoshi;
    • D'Esposito, Maurizio;
    • Luini, Alberto;
    • D'Angelo, Giovanni
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    AKT signaling is associated with epigenetic reprogramming via the upregulation of TET and its cofactor, alpha-ketoglutarate during iPSC generation.

    Published in:
    Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02578-1
    By:
    • Sekita, Yoichi;
    • Sugiura, Yuki;
    • Matsumoto, Akari;
    • Kawasaki, Yuki;
    • Akasaka, Kazuya;
    • Konno, Ryo;
    • Shimizu, Momoka;
    • Ito, Toshiaki;
    • Sugiyama, Eiji;
    • Yamazaki, Terushi;
    • Kanai, Eriko;
    • Nakamura, Toshinobu;
    • Suematsu, Makoto;
    • Ishino, Fumitoshi;
    • Kodera, Yoshio;
    • Kohda, Takashi;
    • Kimura, Tohru
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation

    Published in:
    FEBS Letters, 2006, v. 580, n. 18, p. 4387, doi. 10.1016/j.febslet.2006.07.003
    By:
    • Yamada, Toru;
    • Maruyama, Muneharu;
    • Fujita, Tadashi;
    • Miyabayashi, Koutarou;
    • Shinoda, Chie;
    • Kawagishi, Yukio;
    • Fujishita, Takashi;
    • Hayashi, Ryuji;
    • Miwa, Toshiro;
    • Arai, Nobuki;
    • Matsui, Shoko;
    • Sugiyama, Eiji;
    • Kobayashi, Masashi
    Publication type:
    Article
    39
    40
    41

    Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

    Published in:
    Arthritis & Rheumatology, 2020, v. 72, n. 3, p. 488, doi. 10.1002/art.41105
    By:
    • Tsuji, Hideaki;
    • Nakashima, Ran;
    • Hosono, Yuji;
    • Imura, Yoshitaka;
    • Yagita, Masato;
    • Yoshifuji, Hajime;
    • Hirata, Shintaro;
    • Nojima, Takaki;
    • Sugiyama, Eiji;
    • Hatta, Kazuhiro;
    • Taguchi, Yoshio;
    • Katayama, Masaki;
    • Tanizawa, Kiminobu;
    • Handa, Tomohiro;
    • Uozumi, Ryuji;
    • Akizuki, Shuji;
    • Murakami, Kosaku;
    • Hashimoto, Motomu;
    • Tanaka, Masao;
    • Ohmura, Koichiro
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50